News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,409 Results
Type
Article (42564)
Company Profile (294)
Press Release (677551)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (210487)
Career Advice (2092)
Deals (36639)
Drug Delivery (107)
Drug Development (83067)
Employer Resources (175)
FDA (16590)
Job Trends (15418)
News (356135)
Policy (33935)
Tag
Academia (2599)
Accelerated approval (5)
Adcomms (22)
Allergies (92)
Alliances (51458)
ALS (100)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (141)
Approvals (16587)
Artificial intelligence (281)
Autoimmune disease (24)
Automation (17)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (188)
Bladder cancer (81)
Brain cancer (30)
Breast cancer (302)
Cancer (2396)
Cardiovascular disease (190)
Career advice (1753)
Career pathing (31)
CAR-T (164)
Cell therapy (456)
Cervical cancer (20)
Clinical research (67700)
Collaboration (892)
Company closure (2)
Compensation (583)
Complete response letters (25)
COVID-19 (2666)
CRISPR (49)
C-suite (262)
Cystic fibrosis (106)
Data (2407)
Decentralized trials (2)
Denatured (29)
Depression (47)
Diabetes (284)
Diagnostics (6473)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (119)
Drug shortages (28)
Duchenne muscular dystrophy (102)
Earnings (89007)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (115683)
Executive appointments (767)
FDA (18017)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (796)
Gene editing (119)
Generative AI (22)
Gene therapy (343)
GLP-1 (764)
Government (4557)
Grass and pollen (5)
Guidances (174)
Healthcare (19005)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (136)
Indications (31)
Infectious disease (2812)
Inflammatory bowel disease (147)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (101)
Interviews (323)
IPO (16811)
IRA (47)
Job creations (4060)
Job search strategy (1492)
Kidney cancer (10)
Labor market (43)
Layoffs (500)
Leadership (18)
Legal (8383)
Liver cancer (77)
Lung cancer (331)
Lymphoma (166)
Machine learning (9)
Management (59)
Manufacturing (347)
MASH (81)
Medical device (13475)
Medtech (13480)
Mergers & acquisitions (20412)
Metabolic disorders (745)
Multiple sclerosis (85)
NASH (17)
Neurodegenerative disease (104)
Neuropsychiatric disorders (30)
Neuroscience (2004)
NextGen: Class of 2025 (6637)
Non-profit (4529)
Now hiring (41)
Obesity (393)
Opinion (230)
Ovarian cancer (83)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (159)
Partnered (22)
Patents (256)
Patient recruitment (121)
Peanut (49)
People (59356)
Pharmaceutical (91)
Pharmacy benefit managers (22)
Phase I (21008)
Phase II (29798)
Phase III (22306)
Pipeline (1481)
Policy (162)
Postmarket research (2654)
Preclinical (8959)
Press Release (68)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (411)
Real estate (6259)
Recruiting (67)
Regulatory (23207)
Reports (50)
Research institute (2370)
Resumes & cover letters (358)
Rett syndrome (7)
RNA editing (8)
RSV (42)
Schizophrenia (80)
Series A (138)
Series B (93)
Service/supplier (12)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3731)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (57)
The Weekly (50)
Vaccines (722)
Venture capitalists (42)
Weight loss (256)
Women's health (36)
Worklife (16)
Date
Today (136)
Last 7 days (919)
Last 30 days (3565)
Last 365 days (32960)
2025 (12747)
2024 (35770)
2023 (40630)
2022 (51798)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33138)
2016 (32662)
2015 (38616)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (55)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (40791)
Australia (6535)
California (6621)
Canada (2121)
China (561)
Colorado (284)
Connecticut (287)
Delaware (164)
Europe (87200)
Florida (982)
Georgia (220)
Idaho (57)
Illinois (572)
India (26)
Indiana (333)
Iowa (11)
Japan (180)
Kansas (107)
Kentucky (24)
Louisiana (12)
Maine (63)
Maryland (942)
Massachusetts (4950)
Michigan (231)
Minnesota (411)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (70)
New Hampshire (63)
New Jersey (1846)
New Mexico (29)
New York (1859)
North Carolina (1027)
North Dakota (8)
Northern California (2915)
Ohio (213)
Oklahoma (14)
Oregon (39)
Pennsylvania (1462)
Puerto Rico (13)
Rhode Island (33)
South America (1163)
South Carolina (27)
South Dakota (1)
Southern California (2481)
Tennessee (108)
Texas (982)
United States (24800)
Utah (193)
Virginia (166)
Washington D.C. (65)
Washington State (586)
West Virginia (3)
Wisconsin (61)
720,409 Results for "agios pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
May 9, 2025
·
1 min read
Press Releases
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
May 2, 2025
·
1 min read
Press Releases
Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 1, 2025
·
11 min read
Press Releases
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
April 17, 2025
·
1 min read
Press Releases
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
May 14, 2025
·
12 min read
Press Releases
Agios to Present at Upcoming March 2025 Investor Conferences
March 5, 2025
·
1 min read
Genetown
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, announced that data from its programs will be presented at the European Hematology Association 2024 Hybrid Congress, to be held June 13-16, 2024, in Madrid, Spain.
May 14, 2024
·
8 min read
Genetown
Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, announced that the company has agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma.
May 28, 2024
·
6 min read
Genetown
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. ET.
May 3, 2024
·
1 min read
Press Releases
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025
February 20, 2025
·
1 min read
1 of 72,041
Next
